Day: August 27, 2025

NEW YORK and LEAMINGTON, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that it received written notice from the Nasdaq Stock Market, LLC (“Nasdaq”) confirming that Tilray is again in compliance with Nasdaq’s minimum bid price requirement set forth in 5450(a)(1) of the Nasdaq Listing Rules. To achieve this, the Company’s shares were required to close at $1.00 or higher for at least 10 consecutive trading days. According to Nasdaq’s notice, Tilray maintained a closing bid price of at least $1.00 for 10 consecutive trading days from August 13, 2025 to August 26, 2025, thereby meeting the minimum bid price requirement. As a result, Nasdaq...

I forbindelse med udsendelse af delårsrapport for 2. kvartal 2025 forventede PARKEN Sport & Entertainment A/S en omsætning i niveauet 1.600 til 1.700 mio. kr. og et resultat før skat på 100 til 150 mio. kr. Da F.C. København onsdag aften har kvalificeret sig til League Phase i UEFA Champions League, forventer PARKEN Sport & Entertainment A/S nu en omsætning på 1.800 til 1.900 mio. kr. og et resultat før skat på 240 til 290 mio. kr. for 2025. Med venlig hilsenPARKEN Sport & Entertainment A/S Henrik Møgelmose BestyrelsesformandAttachmentSelskabsmeddelelse 19 – 2025 – Forventninger 2025

Kyivstar Nasdaq ListingKyivstar Nasdaq listingNew York, August 27, 2025 – VEON Ltd. (Nasdaq: VEON) (“VEON”), a global digital operator and parent company of Ukraine’s leading digital operator Kyivstar Group Ltd (Nasdaq: KYIV; KYIVW) (“Kyivstar”), are today kicking off a series of strategic engagements in New York to celebrate the first Ukrainian landmark listing on Nasdaq and to officially launch their “Invest in Ukraine NOW!” campaign in the United States. Kyivstar began trading on the Nasdaq Stock Market (“Nasdaq”) on August 15th, becoming the first and only Ukrainian investment opportunity listed on a U.S. stock exchange. To mark the occasion, Kyivstar will be ringing the Nasdaq opening bell on Friday, August 29th. VEON and Kyivstar will also host a series of events earlier in the week, including an investor conference for...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (TSX: ELO; OTCQX: ELRRF; FSE: P2QM) (“Eloro” or the “Company”) is pleased to announce that further to its press releases dated August 22, 2025 and as a result of strong investor demand, the Company has further increased the gross proceeds of its previously announced “bought deal” private placement (the “Underwritten Offering”) from C$10,000,400 to C$11,000,900. Pursuant to the upsized Underwritten Offering, Red Cloud Securities Inc. (“Red Cloud”), as sole underwriter and bookrunner, has agreed to purchase for resale 9,566,000 units of the Company (the “Units”) at a price of C$1.15...

DUBLIN, Ohio, Aug. 27, 2025 (GLOBE NEWSWIRE) — reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced the expansion of its platform into Georgia with the launch of real estate brokerage service through its REALTOR® affiliate. This milestone expands reAlpha’s realty operational footprint into a third major state. Georgia saw over 125,000 home sales in 2024, with a median sale price of $375,000, representing approximately $47 billion in annual residential transaction volume.1 This expansion into the nation’s 8th most populous state2 positions reAlpha to serve a growing base of prospective homebuyers through a tech-enabled platform that delivers real savings at closing, including in markets such as Atlanta, Savannah, Augusta, and Macon.3 “Expanding into Georgia...

REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, today announced that management will participate in the following upcoming investor conferences in September: Cantor Fitzgerald Global Healthcare Conference 2025Conference Dates: September 3-5, 2025Presentation Date/Time: Wednesday, September 3, 2025; 1:00 PM EDTPresentation Format: Fireside Chat H.C. Wainwright 27th Annual Global Investment ConferenceConference Dates: September 8-10, 2025Presentation Date/Time: Tuesday, September 9, 2025; 3:00 PM EDTPresentation Format: Fireside...